nicardipine , a new calcium channel blocking drug of the dihydropyridine family , was administered to 63 patients at a dose of 30 or 40 mg 3 times daily in a multicenter , randomized , double-blind , placebo-controlled , crossover trial .
C0028005
nicardipine
C0012315
dihydropyridine